Centessa Pharmaceuticals(CNTA) - 2024 Q1 - Quarterly Results
Exhibit 99.1 Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024 BOSTON and LONDON, May 13, 2024: Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today reported financial results and business highlights for the first quarter ended March 31, 2024. "2024 is off to a strong start for Centessa. Following clearance of our IND, we recently in ...